跳至主要内容
临床试验/2022-501123-24-00
2022-501123-24-00招募中2 期

Pathophysiology of pain in Parkinson's disease: exploration of the serotonin system in positron emission tomography (PET [18F]-MPPF) - PD PAIN

Centre Hospitalier Universitaire De Toulouse1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年5月17日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
34
试验地点
1
主要终点
The primary endpoint is the distribution volume ratio of [18F]-MPPF (DVR) using the cerebellum as the reference region, measured in both groups of painful and non-painful PD patients

研究概览

简要总结

The primary endpoint is the distribution volume ratio of [18F]-MPPF (DVR) using the cerebellum as the reference region, measured in both groups of painful and non-painful PD patients

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Patients with Parkinson's disease defined according to UKPDSBB criteria
  • Men and women aged between 35 and 85 years
  • Patients with stable anti-parkinsonian treatment for at least 2 weeks prior to V2
  • Patients with a MOCA score ≥ 24
  • Patients with a HADS-D score ≤ 11
  • Person affiliated or benefiting from a social security scheme.
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

排除标准

  • Patients treated with second line therapy (deep brain stimulation, pump - duodopa and apokinon)
  • Patients with a history of significant psychiatric pathology according to the investigator
  • Patients treated with drugs interacting with 5HT1A receptors in the previous 2 weeks ( serotonergic antidepressants)
  • Patients with contraindication to MRI
  • Patients refusing to be informed of an abnormality discovered during brain imaging
  • Patients with dyskinesias judged by the investigator to be disabling for imaging
  • Patients under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision
  • Pregnant woman, breastfeeding woman
  •  Triptans taken in the 48 hours preceding PET

结局指标

主要结局

The primary endpoint is the distribution volume ratio of [18F]-MPPF (DVR) using the cerebellum as the reference region, measured in both groups of painful and non-painful PD patients

The primary endpoint is the distribution volume ratio of [18F]-MPPF (DVR) using the cerebellum as the reference region, measured in both groups of painful and non-painful PD patients

次要结局

  • assess the relationship between [18F]-MPPF uptake and :  central pain intensity, other central pain characteristics and pain-induced functional discomfort only in painful parkinsonian patients  pain perception thresholds in the 2 groups of patients
  • compare the functional networks related to pain on resting-state functional MRI between the 2 groups of patients;
  • evaluate, for the 2 groups of patients, the link between :  cerebral structural characteristics (cerebral macro/microstructural markers collected in MRI) and pain parameters (central pain intensity, and other pain characteristics, pain-induced functional discomfort and pain perception thresholds);  [18F]-MPPF uptake and pain-related functional networks in resting-state MRI

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

clinical research assistant (sponsor)

Scientific

Centre Hospitalier Universitaire De Toulouse

研究点 (1)

Loading locations...

相似试验